» Articles » PMID: 36015344

Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Aug 26
PMID 36015344
Authors
Affiliations
Soon will be listed here.
Abstract

Injury to lower genitourinary (GU) tissues, which may result in either infertility and/or organ dysfunctions, threatens the overall health of humans. Bioactive agent-based regenerative therapy is a promising therapeutic method. However, strategies for spatiotemporal delivery of bioactive agents with optimal stability, activity, and tunable delivery for effective sustained disease management are still in need and present challenges. In this review, we present the advancements of the pivotal components in delivery systems, including biomedical innovations, system fabrication methods, and loading strategies, which may improve the performance of delivery systems for better regenerative effects. We also review the most recent developments in the application of these technologies, and the potential for delivery-based regenerative therapies to treat lower GU injuries. Recent progress suggests that the use of advanced strategies have not only made it possible to develop better and more diverse functionalities, but also more precise, and smarter bioactive agent delivery systems for regenerative therapy. Their application in lower GU injury treatment has achieved certain effects in both patients with lower genitourinary injuries and/or in model animals. The continuous evolution of biomaterials and therapeutic agents, advances in three-dimensional printing, as well as emerging techniques all show a promising future for the treatment of lower GU-related disorders and dysfunctions.

References
1.
Liang L, Shen Y, Dong Z, Gu X . Photoacoustic image-guided corpus cavernosum intratunical injection of adipose stem cell-derived exosomes loaded polydopamine thermosensitive hydrogel for erectile dysfunction treatment. Bioact Mater. 2021; 9:147-156. PMC: 8586570. DOI: 10.1016/j.bioactmat.2021.07.024. View

2.
Miao T, Wang J, Zeng Y, Liu G, Chen X . Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside. Adv Sci (Weinh). 2018; 5(4):1700513. PMC: 5908359. DOI: 10.1002/advs.201700513. View

3.
Wu J, Zhu J, Wu Q, An Y, Wang K, Xuan T . Mussel-Inspired Surface Immobilization of Heparin on Magnetic Nanoparticles for Enhanced Wound Repair via Sustained Release of a Growth Factor and M2 Macrophage Polarization. ACS Appl Mater Interfaces. 2021; 13(2):2230-2244. DOI: 10.1021/acsami.0c18388. View

4.
Johnson J, Wu Y, Blyth C, Lichtfuss G, Goubran H, Burnouf T . Prospective Therapeutic Applications of Platelet Extracellular Vesicles. Trends Biotechnol. 2020; 39(6):598-612. DOI: 10.1016/j.tibtech.2020.10.004. View

5.
Salem S, Rashidbenam Z, Jasman M, Ho C, Sagap I, Singh R . Incorporation of Smooth Muscle Cells Derived from Human Adipose Stem Cells on Poly(Lactic-co-Glycolic Acid) Scaffold for the Reconstruction of Subtotally Resected Urinary Bladder in Athymic Rats. Tissue Eng Regen Med. 2020; 17(4):553-563. PMC: 7392991. DOI: 10.1007/s13770-020-00271-7. View